PEOPLE - MIV Therapeutics makes appointment:
This article was originally published in Clinica
Executive Summary
Daljeet Gambhir, director of cardiology and CEO of India's Kailash Heart Institute, has been appointed clinical advisor on the medical advisory board of Vancouver, British Columbia-based company MIV Therapeutics. Dr Gambhir will oversee the company's research and human clinical studies in India. MIV Therapeutics develops biocompatible coatings for passive and drug-eluting applications on cardiovascular stents and other implantable devices.